In this presentation, there do have something worth keeping in...

In this presentation, there do have something worth keeping in our shareholders'mind. Though a lot are nearly the same as the Dubai Investor Presentation on 20 April, we can read page 10 carefully,comparing with the summary included in the Dubai presentation.

The new presentation states
✓ 10/12 clients in Medtech✓ 6/12 in production phase✓ 6/12 in R&D phase

The Dubai presentation stated:
▪ 9/10 clients in Medtech▪ 4/10 in production phase▪ 6/10 in R&D phase

Therefore in these four months there are a lot happening behind scene. At least we have two more clients,one more in Medtech and two more clients in production phase.

I am happy with the behind scene activities though I am very scratching my head for the share price.